The global renal replacement therapy market is anticipated to grow at a considerable CAGR of around 7.3% during the forecast period (2021-2027). One of the major factors that drive the market growth includes increasing chronic diseases across the globe. For instance, the two main reasons for kidney disease are patients with diabetes and high blood pressure. These two diseases were the primary diagnosis in 76% of kidney failure cases, and the remaining 29% of patients having hypertension. Diabetes and high blood pressure responsible for up to two-thirds of kidney disease cases, Diabetes occurs when a person’s blood sugar is too high that causes damage to the kidney and several organs of the patient’s body including the heart, and eyes. According to the national kidney foundation, kidney disease causes more mortality rate than prostate cancer or breast cancer. Kidney disease affects around 37 million people in the US in 2021. The total number of patients having kidney failure will likely surpass 1 million by 2030. While about 100,000 Americans are waiting for a kidney transplant, and only 22,817 Americans received one in 2020. About one-third of these transplants came from living donors.
To Request a Sample of our Report on Renal Replacement Therapy Market: https://www.omrglobal.com/request-sample/renal-replacement-therapy-market
Renal replacement therapy replaces nonendocrine kidney function in patients having renal failure. The therapy is recommended when the kidneys are not functioning properly or are eternally damaged. The most possible treatment in renal replacement therapy includes peritoneal dialysis, hemofiltration, hemodialysis, and intermittent hemodialysis. All modalities exchange solute and remove fluid from the blood, using dialysis and purification across permeable membranes. The major driver of the growth of the renal replacement therapy market includes the prevalence of kidney diseases, rising chronic disease, increasing diabetic population, changes in lifestyle such as the problem with kidney is mostly seen in person with smoking habits. COVID-19 is targeting people having kidney disease, kidney transplant patients, and those at risk for kidney disease.
Market Coverage
· The market number available for – 2020-2027
· Base year- 2020
· Forecast period- 2021-2027
Segment Covered-
· By Therapy type
· By End-user
Regions Covered-
· North America
· Europe
· Asia-Pacific
· Rest of the World
Competitive Landscape – Fresenius Medical Care AG & Co., Medica S.p.A., Medtronic, cytosorbents, Baxter.
Key questions addressed by the report
· What is the market growth rate?
· Which segment and region dominate the market in the base year?
· Which segment and region will project the fastest growth in the market?
· How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
· Who is the leader in the market?
· How are players addressing challenges to sustain growth?
· Where is the investment opportunity?
(Get 15% Discount on Buying this Report)
A full Report of Renal Replacement Therapy Market is Available at: https://www.omrglobal.com/industry-reports/renal-replacement-therapy-market
Global Renal Replacement Therapy Market
By Therapy Type
· Dialysis
· Hemodialysis
· Peritoneal Dialysis
By End-User
· Hospitals and Clinics
· Research Institutes
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
